1. Home
  2. CTMX vs ESP Comparison

CTMX vs ESP Comparison

Compare CTMX & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • ESP
  • Stock Information
  • Founded
  • CTMX 2008
  • ESP 1928
  • Country
  • CTMX United States
  • ESP United States
  • Employees
  • CTMX N/A
  • ESP N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • CTMX Health Care
  • ESP Technology
  • Exchange
  • CTMX Nasdaq
  • ESP Nasdaq
  • Market Cap
  • CTMX 444.3M
  • ESP 129.5M
  • IPO Year
  • CTMX 2015
  • ESP N/A
  • Fundamental
  • Price
  • CTMX $2.42
  • ESP $47.61
  • Analyst Decision
  • CTMX Strong Buy
  • ESP
  • Analyst Count
  • CTMX 2
  • ESP 0
  • Target Price
  • CTMX $5.00
  • ESP N/A
  • AVG Volume (30 Days)
  • CTMX 2.4M
  • ESP 29.5K
  • Earning Date
  • CTMX 08-07-2025
  • ESP 05-12-2025
  • Dividend Yield
  • CTMX N/A
  • ESP 2.11%
  • EPS Growth
  • CTMX 128.27
  • ESP 39.20
  • EPS
  • CTMX 0.49
  • ESP 2.67
  • Revenue
  • CTMX $147,557,000.00
  • ESP $45,965,588.00
  • Revenue This Year
  • CTMX N/A
  • ESP N/A
  • Revenue Next Year
  • CTMX N/A
  • ESP N/A
  • P/E Ratio
  • CTMX $4.99
  • ESP $18.47
  • Revenue Growth
  • CTMX 23.81
  • ESP 29.60
  • 52 Week Low
  • CTMX $0.40
  • ESP $20.50
  • 52 Week High
  • CTMX $3.10
  • ESP $49.38
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 52.71
  • ESP 73.32
  • Support Level
  • CTMX $2.33
  • ESP $45.94
  • Resistance Level
  • CTMX $2.79
  • ESP $48.24
  • Average True Range (ATR)
  • CTMX 0.18
  • ESP 1.97
  • MACD
  • CTMX -0.01
  • ESP 0.13
  • Stochastic Oscillator
  • CTMX 46.38
  • ESP 90.14

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: